发明名称 NMDA NR2B antagonists for treatment
摘要 The invention provides new methods for treating certain disorders resulting from neurodegeneration and for treating depression which comprise administration of NR2B subunit selective NMDA antagonists. The disorders that can be treating by the invention include hearing loss, vision loss, neurodegeneration caused by epileptic seizures, neurotoxin poisoning, Restless Leg Syndrome, multi-system atrophy, non-vascular headache, and depression.
申请公布号 US2004162312(A1) 申请公布日期 2004.08.19
申请号 US20010969318 申请日期 2001.10.02
申请人 CHENARD BERTRAND L. 发明人 CHENARD BERTRAND L.
分类号 A61K45/00;A61K31/00;A61K31/05;A61K31/4015;A61K31/445;A61K31/452;A61K31/4525;A61K31/453;A61K31/46;A61P25/00;A61P25/24;A61P25/28;A61P27/00;A61P27/02;A61P27/06;A61P27/16;A61P43/00;(IPC1-7):A61K31/46;A61K31/402;A61K31/401 主分类号 A61K45/00
代理机构 代理人
主权项
地址